PharmAlliance, a diversified pharmaceutical and life sciences services platform, is pleased to announce the acquisition of Complete Health Economics Outcomes Research Solutions—CHEORS—a leading provider of health economics and outcomes research (HEOR) and market access services across the pharmaceutical, biotechnology, and medical device industries. With this addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities. CHEORS marks the third strategic acquisition for PharmAlliance, a portfolio company of Waud Capital Partners.
Read the full article: PharmAlliance Announces Acquisition of CHEORS //
Source: https://www.businesswire.com/news/home/20240416800738/en/PharmAlliance-Announces-Acquisition-of-CHEORS